About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Illinois | 118 Studies

Clinical Trials Brain CancerIllinois

Brain Cancer Clinical Trials in Illinois

Find 118 clinical trials for brain cancer near Illinois. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 118 trials

TerminatedPost-approval Study of NovoTTF-100A in Recurrent GBM PatientsThis is a non-randomized, concurrent control study, designed to confirm that the efficacy of the NovoTTF-100A System in patients with recurrent GBM treated in a real life settings…NCT01756729·Birmingham, Alabama and 11 others RecruitingBeginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareThis is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows: * A Screening/Baseline Period of 21 days.NCT07195591·Scottsdale, Arizona and 21 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryThis randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be…NCT01814813·Anchorage, Alaska and 416 others

CompletedA Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaThe purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can…NCT01498328·Birmingham, Alabama and 44 others

CompletedBevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or GliosarcomaThis randomized phase II trial is studying the side effects and how well giving bevacizumab together with irinotecan or temozolomide works in treating patients with recurrent or…NCT00433381·Mobile, Alabama and 92 others

UnknownSafety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaThe purpose of this study is to evaluate the safety and biologically active dose of TM-601 in adult patients with recurrent malignant glioma.NCT00591058·Birmingham, Alabama and 6 others

CompletedAdult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade GliomasThis study was conducted to evaluate the efficacy and safety of depatuxizumab mafodotin (ABT-414) alone or with temozolomide versus temozolomide or lomustine alone in adult…NCT02343406·Palo Alto, California and 101 others

CompletedStudy of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsIn this study, investigators will conduct a phase I/II trial in recurrent (temozolomide resistant) glioma patients.NCT02052648·Castro Valley, California and 16 others

RecruitingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossThis is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss.NCT06810544·Scottsdale, Arizona and 14 others

TerminatedMK0752 in Treating Young Patients With Recurrent or Refractory CNS CancerRATIONALE: MK0752 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00572182·San Francisco, California and 11 others

CompletedBevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00720356·Los Angeles, California and 8 others

WithdrawnStudy of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma MultiformeTransMID treatment or best standard of care for patients with advanced glioblastoma multiforme Glioblastoma multiforme (GBM) is a type of brain tumour.NCT00083447·La Jolla, California and 24 others

CompletedBevacizumab in Treating Patients With Recurrent or Progressive GliomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00337207·Chicago, Illinois and 1 other

CompletedBevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00621686·Scottsdale, Arizona and 203 others

CompletedValproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsRATIONALE: Drugs used in chemotherapy, such as valproic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00107458·Orange, California and 16 others

CompletedA Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationThis study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs…NCT02573324·Phoenix, Arizona and 211 others

CompletedSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasThis phase I trial studies the side effects and best dose of selinexor in treating younger patients with solid tumors or central nervous system (CNS) tumors that have come back…NCT02323880·Birmingham, Alabama and 22 others

CompletedHigh-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy, such as methotrexate, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00082797·Aurora, Illinois and 64 others

CompletedS0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or GliosarcomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00017147·Anchorage, Alaska and 162 others

Completedp28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsThis phase I trial studies the side effects and best dose of azurin-derived cell-penetrating peptide p28 (p28) in treating patients with recurrent or progressive central nervous…NCT01975116·Los Angeles, California and 10 others

PreviousPage 3 of 6Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia